In the case of breast cancer treatment, a crucial step is to test the tumor tissue to determine if it has estrogen receptors (ER), progesterone receptors (PR), and/or human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene ERBB2 and neoplasm.